D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
LUNG holding history
Pulmonx Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LUNG overviewAll 13F holders of LUNGFull Q2 2026 holdings
- Shares (Q2 2026)
- 327,528
- Value
- $425.8K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 327,528 | $425.8K | <0.1% | −7,546−2.3% | Reduced | Holders |
| Q1 2026 | 335,074 | $432.2K | <0.1% | −226,192−40.3% | Reduced | Holders |
| Q4 2025 | 561,266 | $1.24M | <0.1% | −227,983−28.9% | Reduced | Holders |
| Q3 2025 | 789,249 | $1.28M | <0.1% | +299,369+61.1% | Added | Holders |
| Q2 2025 | 489,880 | $1.27M | <0.1% | +3,325+0.7% | Added | Holders |
| Q1 2025 | 486,555 | $3.27M | <0.1% | +93,719+23.9% | Added | Holders |
| Q4 2024 | 392,836 | $2.67M | <0.1% | +32,049+8.9% | Added | Holders |
| Q3 2024 | 360,787 | $2.99M | <0.1% | −18,231−4.8% | Reduced | Holders |
| Q2 2024 | 379,018 | $2.40M | <0.1% | −52,279−12.1% | Reduced | Holders |
| Q1 2024 | 431,297 | $4.00M | <0.1% | −191,291−30.7% | Reduced | Holders |
| Q4 2023 | 622,588 | $7.94M | <0.1% | −45,770−6.8% | Reduced | Holders |
| Q3 2023 | 668,358 | $6.90M | <0.1% | −48,020−6.7% | Reduced | Holders |
| Q2 2023 | 716,378 | $9.39M | <0.1% | +142,214+24.8% | Added | Holders |
| Q1 2023 | 574,164 | $6.42M | <0.1% | +320,174+126.1% | Added | Holders |
| Q4 2022 | 253,990 | $2.14M | <0.1% | +253,990 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −23,636−100.0% | Sold out | Holders |
| Q1 2021 | 23,636 | $1.08M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.